Privi Speciality Chemicals: Sustained Growth and Strategic Expansion in Q3 FY26

Privi Speciality Chemicals Limited has once again demonstrated a robust financial performance, reporting strong growth for the third quarter and nine months ended December 31, 2025. Despite a challenging global environment marked by geopolitical uncertainties and tariff impacts, the company has maintained a resilient growth trajectory, driven by its diversified product mix, operational efficiencies, and disciplined project execution. The company's consolidated total income for Q3 FY26 stood at Rs. 611.15 crore, marking a 24% year-on-year increase from Rs. 493.06 crore in Q3 FY25. EBITDA surged by 37% to Rs. 157.85 crore, up from Rs. 115.00 crore in the prior year, with PAT attributable to the company rising significantly by 76% to Rs. 77.99 crore.

For the nine-month period, the consolidated total income reached Rs. 1,857.23 crore, a 24% increase from Rs. 1,493.47 crore in 9M FY25. EBITDA for this period grew by an impressive 47% to Rs. 481.04 crore, while PAT attributable to the company soared by 94% to Rs. 233.84 crore. These figures underscore Privi's ability to protect profitability across cycles and reinforce confidence in the structural strength of its operations. The company has consistently delivered EBITDA margins above 20% for the past ten quarters, with the last three quarters exceeding 25%, a testament to its operational excellence and improved product mix.

Strategic Growth Roadmap and Expansion Initiatives

Privi Speciality Chemicals is actively pursuing a clearly defined 3-phase expansion roadmap to sustain and accelerate its growth momentum. This strategy aligns with its long-term vision to achieve Rs. 5,000 crore in revenue and Rs. 1,000 crore in EBITDA over the next 3-4 years. Phase 1, focusing on capacity expansion for existing products, is nearing completion and is expected to be commercialized by end of March or April 2026. This will increase the production capacity from 48,000 metric tons to 54,000 metric tons. Phase 2, involving multi-speciality aroma chemicals projects, is also progressing as planned, with civil work halfway complete and detailed engineering activities on track. The total investment for these three phases is estimated at Rs. 1,200 crore, with Rs. 300 crore for Phase 1, Rs. 600 crore for Phase 2, and Rs. 300 crore for Phase 3, expected to be completed by March 2027-28.

Innovation and sustainability are core to Privi's value creation journey. The company is investing in green chemistry, biotechnology, and intellectual property to expand its addressable markets. The technology group is making significant progress in scaling technologies to convert biomass (biowaste) into value-added products, which is expected to generate substantial intellectual property. For instance, Privi aims to be the first company globally to offer Cyclopentanone manufactured through a bio-route using renewable raw materials. This focus on sustainable solutions is further evidenced by its Ecovadis Platinum rating, placing it in the top 1% globally for Environment, Labor, Ethics, and Sustainable Procurement.

Joint Venture Progress and Market Positioning

The joint venture with Givaudan, Prigiv, is showing promising progress, having achieved positive EBITDA in Q3 FY26, with net profit anticipated in the next financial year. To capitalize on growth opportunities, Privi and Givaudan will infuse an additional equity capital of Rs. 50 crore for immediate expansion. Furthermore, Givaudan has agreed to provide a non-interest bearing trade advance of approximately Rs. 150 crore to reduce Prigiv's debt burden and interest costs, reinforcing Givaudan's commitment to the project. This strategic partnership is expected to create capacities for additional products and scale up medium-sized specialty molecules.

Privi's strategic positioning is strengthened by India's emergence as a hub for specialty chemicals. The company is leveraging advanced manufacturing technologies, process automation, and real-time analytics to enhance efficiency and scalability. With a significant portion of its products exported, Privi anticipates a clear advantage from evolving trade landscapes, particularly with the EU treaty and the lifting of US tariffs, which could result in duty benefits of 18% or even 0% for its product range. The company's backward integration into key raw materials like Crude Sulphate Turpentine (CST) and Gum Turpentine Oil (GTO) ensures supply security and cost efficiency, making it one of only four companies globally with this technology.

Outlook and Future Trajectory

Privi Speciality Chemicals is on track to achieve its vision of Rs. 5,000 crore revenue and Rs. 1,000 crore EBITDA in the next 3-4 years, representing more than 2x growth. The management expects EBITDA margins to sustain north of 20%, driven by continued operational efficiency and an enhanced product mix. The company's debt-to-EBITDA ratio stands at a healthy 1.6x, well within its target of less than 2.5x, indicating disciplined financial management. With ongoing capacity expansions, new product developments, and a strong commitment to sustainability and innovation, Privi is well-positioned to capitalize on global opportunities and deliver sustained long-term growth.